Global Pidotimod Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
USD Million/Billion
Loading…
Share Distribution
Loading…
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Global Pidotimod Market Analysis — Presence
Interactive World Map
Click countries to explore
Loading map…
Regional and Country Analysis
North America — United States, Canada, Mexico
Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
Africa — East Africa, West Africa, North Africa, South Africa
Segmentation Analysis
Market size by (Illustrative, 2025)
Share distribution (2025)
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Competitive Landscape of the Global Pidotimod Market Analysis
In no particular order of rank
Company Profile:
Merck KGaA (Sigma Aldrich)
Merck company is leader in science and technology, which boost its growth in market through innovation and advancement in the product portfolio. Company is leader in life science segment and post-acquisition it has significant presence across all regions along with investment in the life science industry in order to strengthen its presence in the market. Merck KGaA has wide range product portfolio in the market in healthcare, life science and performance materials segments, among which healthcare is biggest segment includes biopharma and allergopharma subsegments in it. The API product include Pidotimod that effectively used in treatment of acute recurrent respiratory tract infections. The company’s life science segment comprises of biopharmaceuticals and high-grade chemicals manufacturing such as chemical synthesis of thiols or mercaptans and other organic or inorganic chemicals, analytical chromatography products, life science, material science. The performance material segment includes specialty chemical business of Merck and supply solutions for displays, electronic chips and other. The Merck company has a subsidiary named Sigma Aldrich or currently operated under Sigma Millipore name is a part of Merck KGaA company. After acquisition with Sigma Aldrich, company serves life science segment handling established brands such as SAFC and Bio reliance. SAFC is a fine chemical supply branch, which is specialized in raw materials for cell culture, manufacturing of active pharmaceutical ingredients. It has skilled professionals, which are specialized in healthcare, life science and performance material segment and provide unique solutions to customers.
RECENT NEWS
October 2020
Merck Company Merged with Mammoth Company
Merck Company collaborates with Mammoth company in Life sciences segment for the development and production of Mammoth’s CRISPR-based SARS Cov-2 diagnostic test.
July 2020
Merck company announced Expansion of Life Science Segment
Merck Company announces expansion of their Life Science segment production capacities in the Unites States. The announced to strengthen and expand their manufacturing foot prints with significant investment at its production facility in Danvers, Massachusetts, Jaffrey, New Hampshire, USA.
Dr Reddy’s Laboratories Ltd.
Dr. Reddy Laboratories is an integrated pharmaceutical company committed to provide affordable and innovative medicines for ensuring healthy wellbeing of customers. Dr Reddy's company is specialized in manufacturing and supply of quality API including Pidotimod, generic medicines. The company is preferred API partner to other pharma companies in supply of API, generic products across US, Europe, Latin America, Japan, China, Korea and emerging markets. The portfolio includes generic medicines containing tablets, capsules, injectables, and topical creams, is the largest part of our business portfolio, making products across the major therapeutic areas of gastrointestinal ailments, cardiovascular disease, pain management, oncology, anti-infective, pediatrics and dermatology. The other two segment includes pharmaceutical services and active pharmaceutical ingredient such as Pidotimod, proprietary product segment. Company has offered more than 200 high quality generic versions of expensive innovator medicines at low-cost.
RECENT NEWS
2020
Dr. Reddy Laboratories has Collaborated with Fujifilm and Global Response Aid
Dr Reddy's Laboratories has collaborated with Fujifilm and Global Response Aid for distributing Avigan (Favipir) and acquired licensing rights for Redyx (Remdesivir) offered in 127 countries.
Click any bar or cell to request the full company profile
Company
2022 (A)
2023 (A)
2024 (A)
2025 (A)
Polifarma S.p.A.
•••
•••
•••
•••
Zambon Group S.p.A.
•••
•••
•••
•••
Chiesi Farmaceutici S.p.A.
•••
•••
•••
•••
Laboratorios Salvat S.A.
•••
•••
•••
•••
Italfarmaco S.p.A.
•••
•••
•••
•••
Boehringer Ingelheim International GmbH
•••
•••
•••
•••
Mylan N.V.
•••
•••
•••
•••
Teva Pharmaceutical Industries Ltd.
•••
•••
•••
•••
Sanofi S.A.
•••
•••
•••
•••
Pfizer Inc.
•••
•••
•••
•••
Novartis AG
•••
•••
•••
•••
GlaxoSmithKline plc
•••
•••
•••
•••
AstraZeneca plc
•••
•••
•••
•••
Roche Holding AG
•••
•••
•••
•••
Merck & Co.
•••
•••
•••
•••
Inc.
•••
•••
•••
•••
Others
•••
•••
•••
•••
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
As per Cognitive Market Research's latest published report, the Global Pidotimod market size will be $2,344.84 Million by 2028. The Global Pidotimod Industry's Compound Annual Growth Rate will be 14.42% from 2023 to 2030.
Asia Pacific Pidotimod market size will be USD 2,076.95 Million in 2028.
Introduction of Pidotimod
Pidotimod is an Immunostimulant, it works by modulating the immune system to trigger a protective response against bacteria or viruses that cause recurrent airway infections, this boosts immunity against these infections. The common side effects associated with Pidotimod is skin rash. Pidotimod medicine is boosting the immune system and activates cells in the blood to fight against germs to protect us from respiratory infections.
The market of Pidotimod is classified into various types including Piece, oral liquid, capsule, particle and Application of Pidotimod is in gynecology, urinary, respiratory tract infection.
The market for Pidotimod immunostimulant is increasing boosting the growth of market due to its benefit and efficacy provided in the treatment of respiratory infections in children with asthma or without asthma, Chronic Bronchitis, Chronic obstructive pulmonary disease.
For Instance, Acute respiratory infections are very common across all regions. There is increasing prevalence of acute respiratory infection cases in children, adult population due to pollution, smoking habits, sedentary lifestyle, lack of exercise. The global Burden of Disease Study stated lower respiratory infection led to death of around 2.73 million people.
Hence the Pidotimod medicine has proven as effective in boosting the immunity in the patients with respiratory infections, the consumption or treatment of Pidotimod Immune stimulant reduces the severity and recurrent episodes of respiratory infection in children and adults. The efficacy and quality of pidotimod is proven for effectively treating the respiratory infection such as Recurrent respiratory infection, asthma, bronchitis, chronic obstructive pulmonary disease (COPD).
The clinical studies have proven that immunostimulant activity of pidotimod has established its prominence and it efficiently helps in management of recurrent respiratory infections in children with or without asthma and significantly prevents the recurrent infection and reduces the severity and duration of acute episodes, ultimately resulting in reduced visits to pediatric clinics and lower absenteeism at school. This benefits and efficacy of Pidotimod immunostimulant boost the growth of market.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Pidotimod Market Analysis is witnessing significant growth in the near future. In 2023, the Tablets
segment accounted for a notable share of the Global Pidotimod Market Analysis.
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Pidotimod Market Analysis is witnessing significant growth in the near future.
In 2023, the Tablets
segment accounted for a notable share of the Global Pidotimod Market Analysis.
Supriya Yadav
Research Analyst · Cognitive Market Research
As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.
My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.
I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.
The Global Pidotimod Market size was valued at USD 1,040.78 Million in 2022.
Active Peptide Company, Reco Tech, Manus Aktteva Biopharma, Joyochem, Changzhou Yinsheng Pharmaceutical, Dr. Reddys, Merck KGaA (Sigma Aldrich) are the key players operating in the market.
In terms of revenue,Capsules/ Tablets form segment accounted for 64.12% of total the global Pidotimod Market share in 2022.
The Respiratory Infections is expected to register CAGR of 15.01% within the forecast period.
In terms of revenue, Asia Pacific was the dominated region with 86.48% of total market in 2022.
The factors that restraint the market growth are Growing Prevalence of the Cardiovascular and Chronic Diseases, Rising prevalence of the urinary tract infections.
★ Reviews
No reviews yet — be the first!
Rate this report
Global Pidotimod Market Analysis — Table of Contents
Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
19.6 Future Gross Margin Outlook and Profitability Trends
20.1 Key Takeaways
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study.
You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
20.2 Analyst Point of View
20.3 Assumptions and Acronyms
21.1 Primary Data Collection
21.1.1 Steps for Primary Data Collection
21.1.1.1 Identification of KOL
21.1.2 Backward Integration
21.1.3 Forward Integration
21.1.4 How Primary Research Help Us
21.1.5 Modes of Primary Research
21.2 Secondary Research
21.2.1 How Secondary Research Help Us
21.2.2 Sources of Secondary Research
21.3 Data Validation
21.3.1 Data Triangulation
21.3.2 Top Down & Bottom Up Approach
21.3.3 Cross check KOL Responses with Secondary Data
21.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Pidotimod Market Analysis Market analysis.
01
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
02
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
03
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
04
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
05
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Pidotimod Market Analysis market.
Service 01
Market Survey
B2BB2C
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global pidotimod market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
What's Included
Buyer intent & sentiment analysis
Purchase cycle mapping
Price sensitivity research
Channel preference profiling
Competitive perception study
Most Requested
Service 02
Customized Market Data & Reports
CustomReady Report
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
What's Included
Ready syndicate report (250+ pages)
Custom data scope & segmentation
Excel quantitative models
Board-ready PPT with key findings
Secure cloud portal access
Service 03
Strategic Consultation
With SurveyWith Report
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
What's Included
Dedicated analyst assigned to you
Live walkthrough of findings
Strategic Q&A sessions
Go-to-market recommendations
NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
